Failed Impurities/Degradation Specifications
Prescription Drugs
💊 Drugs • 12,141 recalls
Failed Dissolution Specifications
Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10
Sagent Pharmaceuticals
Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.
Failed Impurities/Degradation Specifications
Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05
Sagent Pharmaceuticals
Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.
Subpotent Drug
Subpotent Drug
Subpotent Drug
AMLODIPINE BESYLATE TABLETS USP, 10 mg*, 1000 count bottles (NDC 0603-2110-32), Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811
Qualitest Pharmaceuticals
Failed tablet specifications: One lot was found to contain oversized tablets.
Subpotent Drug
Presence of Foreign Substance; oxidized steel, organic material and shredded polypropylene
Presence of Particulate Matter: lot is not meeting the specification limit for number of particles present in the solution.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Non-Sterility: Confirmed customer complaint of particulate matter floating within the solution of the primary container, consistent with mold.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.
Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.